NO20053023L - Synergistisk kombinasjon omfattende roflumilas og (R,R)-formoterol - Google Patents

Synergistisk kombinasjon omfattende roflumilas og (R,R)-formoterol

Info

Publication number
NO20053023L
NO20053023L NO20053023A NO20053023A NO20053023L NO 20053023 L NO20053023 L NO 20053023L NO 20053023 A NO20053023 A NO 20053023A NO 20053023 A NO20053023 A NO 20053023A NO 20053023 L NO20053023 L NO 20053023L
Authority
NO
Norway
Prior art keywords
formoterol
roflumilase
combination including
synergistic combination
synergistic
Prior art date
Application number
NO20053023A
Other languages
English (en)
Other versions
NO334148B1 (no
Inventor
Rolf Beume
Christian Weimar
Stefan-Lutz Wollin
Degenhard Marx
Daniela Bundschuh
Original Assignee
Takeda Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Gmbh filed Critical Takeda Gmbh
Publication of NO20053023L publication Critical patent/NO20053023L/no
Publication of NO334148B1 publication Critical patent/NO334148B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Oppfinnelsen vedrører den kombinerte administrasjon av roflumilast og R,R-formoterol for behandlingen av lidelser i det respiratoriske system.
NO20053023A 2002-11-27 2005-06-20 Synergistisk kombinasjon omfattende roflumilast og (R,R)-formoterol NO334148B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02026504 2002-11-27
PCT/EP2003/013266 WO2004047828A1 (en) 2002-11-27 2003-11-26 Synergistic combination compresing roflumilas and (r.r) -formoterol

Publications (2)

Publication Number Publication Date
NO20053023L true NO20053023L (no) 2005-06-20
NO334148B1 NO334148B1 (no) 2013-12-16

Family

ID=32338001

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053023A NO334148B1 (no) 2002-11-27 2005-06-20 Synergistisk kombinasjon omfattende roflumilast og (R,R)-formoterol

Country Status (31)

Country Link
US (1) US20060199865A1 (no)
EP (1) EP1567140B1 (no)
JP (1) JP2006508993A (no)
KR (1) KR20050094810A (no)
CN (1) CN1713902A (no)
AT (1) ATE399544T1 (no)
AU (1) AU2003288169B8 (no)
BR (1) BR0316475A (no)
CA (1) CA2506956C (no)
CO (1) CO5690571A2 (no)
CY (1) CY1110368T1 (no)
DE (1) DE60321954D1 (no)
DK (1) DK1567140T3 (no)
EA (1) EA009990B1 (no)
ES (1) ES2309374T3 (no)
HR (1) HRP20050580B1 (no)
IL (1) IL168307A (no)
IS (1) IS2576B (no)
MA (1) MA27538A1 (no)
ME (1) ME00488B (no)
MX (1) MXPA05005438A (no)
NO (1) NO334148B1 (no)
NZ (1) NZ540658A (no)
PL (1) PL214869B1 (no)
PT (1) PT1567140E (no)
RS (1) RS51082B (no)
SI (1) SI1567140T1 (no)
TN (1) TNSN05130A1 (no)
UA (1) UA83017C2 (no)
WO (1) WO2004047828A1 (no)
ZA (1) ZA200503307B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
ES2335498T3 (es) 2003-03-10 2010-03-29 Nycomed Gmbh Nuevo proceso para la preparacion de reflumilast.
US8663694B2 (en) 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast
WO2013077830A1 (en) * 2011-11-25 2013-05-30 Mahmut Bilgic Synergistilly active combinations of roflumilast and carmoterol
CN103784443A (zh) * 2014-02-18 2014-05-14 青岛市城阳区人民医院 一种包含沙美特罗和罗氟司特的药物组合产品

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
WO1998021175A1 (en) * 1996-11-11 1998-05-22 Sepracor, Inc. Process for the preparation of optically pure isomers of formoterol
AU734122B2 (en) * 1997-02-17 2001-06-07 Takeda Gmbh Compositions for the treatment of ARDS or IRDS containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4- (difluoromethoxy)benzamide and lung surfactant
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
ES2302350T3 (es) * 1997-02-28 2008-07-01 Nycomed Gmbh Combinacion sinergica de inhibidores de pde y agonistas de adenilatociclasa o agonistas de guanililciclasa.
BR9913152A (pt) * 1998-08-26 2001-05-15 Smithkline Beecham Corp Terapias para tratamento de doenças pulmonares
US6303145B2 (en) * 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
CA2715683A1 (en) * 1999-08-21 2001-03-01 Nycomed Gmbh Synergistic combination
GB0103630D0 (en) * 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
ES2296923T3 (es) * 2001-03-22 2008-05-01 Glaxo Group Limited Derivados formanilidas como agonistas del adrenorreceptor beta2.
KR100831534B1 (ko) * 2001-04-30 2008-05-22 글락소 그룹 리미티드 17.알파 위치에 시클릭 에스테르기를 지닌 항염증성의안드로스탄의 17.베타.-카르보티오에이트 에스테르 유도체

Also Published As

Publication number Publication date
DE60321954D1 (de) 2008-08-14
KR20050094810A (ko) 2005-09-28
CY1110368T1 (el) 2015-04-29
EA009990B1 (ru) 2008-04-28
NO334148B1 (no) 2013-12-16
RS20050383A (sr) 2007-08-03
ZA200503307B (en) 2006-11-29
EP1567140B1 (en) 2008-07-02
HRP20050580A2 (en) 2006-08-31
UA83017C2 (uk) 2008-06-10
PL375632A1 (en) 2005-12-12
PT1567140E (pt) 2008-09-24
IS2576B (is) 2010-02-15
DK1567140T3 (da) 2008-11-03
SI1567140T1 (sl) 2008-12-31
CA2506956A1 (en) 2004-06-10
HK1081862A1 (en) 2006-05-26
AU2003288169B2 (en) 2010-01-07
CA2506956C (en) 2012-10-02
ES2309374T3 (es) 2008-12-16
AU2003288169A1 (en) 2004-06-18
JP2006508993A (ja) 2006-03-16
AU2003288169B8 (en) 2010-08-26
BR0316475A (pt) 2005-10-11
EA200500865A1 (ru) 2005-12-29
IL168307A (en) 2010-12-30
CO5690571A2 (es) 2006-10-31
MXPA05005438A (es) 2005-08-03
ATE399544T1 (de) 2008-07-15
EP1567140A1 (en) 2005-08-31
CN1713902A (zh) 2005-12-28
IS7899A (is) 2005-06-20
MA27538A1 (fr) 2005-09-01
NZ540658A (en) 2007-03-30
US20060199865A1 (en) 2006-09-07
PL214869B1 (pl) 2013-09-30
HRP20050580B1 (hr) 2014-04-11
ME00488B (me) 2011-10-10
WO2004047828A1 (en) 2004-06-10
RS51082B (sr) 2010-10-31
TNSN05130A1 (en) 2007-05-14

Similar Documents

Publication Publication Date Title
DK1212089T3 (da) Synergistisk kombination af Roflumilast og Salmeterol
DE60331236D1 (de) Orale zusammensetzungen zur behandlung von diabetes
MXPA05006670A (es) Administracion de capsaicinoides.
WO2004043341A3 (en) Treatment for hemorrhagic shock
CY1110369T1 (el) Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη
MXPA05012358A (es) Combinacion farmaceutica que comprende modafinilo y otra droga.
EA200500328A1 (ru) Композиция и лекарственное средство для лечения респираторных заболеваний, аллергических заболеваний, астмы и/или хронических обструктивных заболеваний легких и способ получения лекарственного средства
NZ591136A (en) A composition for treating aids and associated conditions comprising plant extracts
CY1110368T1 (el) Συνεργιστικος συνδυασμος ο οποιος περιλαμβανει ροφλουμιλαστη και (r,r)-φορμοτερολη

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ASTRAZENECA AB, SE

MM1K Lapsed by not paying the annual fees